Filing Details
- Accession Number:
- 0001415889-25-018822
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-01 20:32:14
- Reporting Period:
- 2025-06-27
- Filing Date:
- 2025-07-01
- Accepted Time:
- 2025-07-01 20:32:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1689375 | Entrada Therapeutics Inc. | TRDA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1219014 | M Scott Rocklage | C/O 5Am Venture Management, Llc 4 Embarcadero Center, Suite 3110 San Francisco CA 94111 | No | No | Yes | No | |
1598549 | J. Andrew Schwab | C/O 5Am Venture Management, Llc 4 Embarcadero Center, Suite 3110 San Francisco CA 94111 | No | No | Yes | No | |
1674324 | 5Am Ventures V, L.p. | C/O 5Am Venture Management, Llc 4 Embarcadero Center, Suite 3110 San Francisco CA 94111 | No | No | No | No | |
1753000 | 5Am Opportunities I, L.p. | C/O 5Am Venture Management, Llc 4 Embarcadero Center, Suite 3110 San Francisco CA 94111 | No | No | Yes | No | |
1790778 | 5Am Opportunities I (Gp), Llc | C/O 5Am Venture Management, Llc 4 Embarcadero Center, Suite 3110 San Francisco CA 94111 | No | No | Yes | No | |
1791889 | 5Am Partners V, Llc | C/O 5Am Venture Management, Llc 4 Embarcadero Center, Suite 3110 San Francisco CA 94111 | No | No | Yes | No |
Transaction Summary
Sold: | 125,000 shares | Avg. Price: $6.93 | Total Value: $866,632.50 |
Number of Shares After Transactions: | 1,100,248 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-06-27 | 55,735 | $6.91 | 3,220,287 | No | 4 | S | Direct | |
Common Stock | Disposition | 2025-06-27 | 19,265 | $6.91 | 1,113,092 | No | 4 | S | Indirect | By 5AM Opportunities I, L.P. |
Common Stock | Disposition | 2025-06-30 | 18,578 | $6.81 | 3,201,709 | No | 4 | S | Direct | |
Common Stock | Disposition | 2025-06-30 | 6,422 | $6.81 | 1,106,670 | No | 4 | S | Indirect | By 5AM Opportunities I, L.P. |
Common Stock | Disposition | 2025-07-01 | 18,578 | $7.12 | 3,183,131 | No | 4 | S | Direct | |
Common Stock | Disposition | 2025-07-01 | 6,422 | $7.12 | 1,100,248 | No | 4 | S | Indirect | By 5AM Opportunities I, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Indirect | By 5AM Opportunities I, L.P. |
No | 4 | S | Direct | |
No | 4 | S | Indirect | By 5AM Opportunities I, L.P. |
No | 4 | S | Direct | |
No | 4 | S | Indirect | By 5AM Opportunities I, L.P. |
Footnotes
- Shares are held by 5AM Ventures V, L.P. ("5AM V"). 5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock held by 5AM V, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports.
- Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held by Opportunities, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports.